ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) has 199 institutional investors that have filed 13F reports for the period ending March 2026.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 31 Mar, 2026 | 10,860,977 | 0 | 0.00% | $87,213,645.00 |
| ORBIMED ADVISORS LLC | 31 Mar, 2026 | 8,288,510 | 0 | 0.00% | $66,556,735.00 |
| Rubric Capital Management LP | 31 Mar, 2026 | 8,000,000 | 1,800,000 | 29.03% | $64,240,000.00 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 31 Mar, 2026 | 7,503,812 | 0 | 0.00% | $60,255,610.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Mar, 2026 | 5,982,919 | 2,814,513 | 88.83% | $48,042,840.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 5,012,254 | -73,063 | -1.44% | $40,248,399.00 |
| Aberdeen Group plc | 31 Mar, 2026 | 4,113,617 | 557,568 | 15.68% | $33,032,345.00 |
| SR ONE CAPITAL MANAGEMENT, LP | 31 Mar, 2026 | 4,012,903 | 0 | 0.00% | $32,223,611.00 |
| State Street Corp | 31 Mar, 2026 | 3,644,966 | 421,385 | 13.07% | $29,269,077.00 |
| Franklin Resources Inc | 31 Mar, 2026 | 3,278,549 | 735,452 | 28.92% | $26,326,745.00 |
| Tyro Capital Management LLC | 31 Mar, 2026 | 2,968,599 | -1,021,105 | -25.59% | $23,837,850.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 2,542,504 | 2,542,504 | 0.00% | $20,416,307.00 |
| UBS Group AG | 31 Mar, 2026 | 2,260,325 | 49,459 | 2.24% | $18,150,410.00 |
| Janney Montgomery Scott LLC | 31 Mar, 2026 | 2,016,464 | 728,632 | 56.58% | $16,192.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 1,773,188 | -181,284 | -9.28% | $14,238,699.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,526,824 | -26,046 | -1.68% | $12,263,317.00 |
| ADAR1 Capital Management, LLC | 31 Mar, 2026 | 1,361,536 | 622,398 | 84.21% | $10,933,134.00 |
| BAMCO INC /NY/ | 31 Mar, 2026 | 1,273,341 | 4,809 | 0.38% | $10,224,928.00 |
| Third Point LLC | 31 Mar, 2026 | 1,000,000 | 443,763 | 79.78% | $8,030,000.00 |
| General American Investors Co Inc | 31 Mar, 2026 | 727,154 | 167,195 | 29.86% | $5,839,047.00 |